The challenge of cost-effectiveness research on first-episode psychosis.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 31196246.
- Also identified by DOI 10.1192/bjp.2019.78.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Early intervention in psychosis has generated hope. Cost-effectiveness studies, to determine whether benefits exceed costs, thus far conclude only that early intervention 'might be' worth its costs. It is a testament to the importance of the question: even in the absence of conclusive data, a synthesis should be attempted.Declaration of interestNone.
Medical subject headings
- Psychotic Disorders
- Schizophrenia